Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Portal hypertension management

J Terblanche1

  • 1Department of Surgery, University of Cape Town, South Africa.

Surgical Endoscopy
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Injection sclerotherapy is a primary treatment for esophageal variceal bleeding. Alternative and investigational therapies are discussed for refractory cases and long-term management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Report of Powdery Mildew of Kenaf Caused by Leveillula taurica in South Africa.

Plant disease·2019
Same author

First Report of Botrytis cinerea on Kenaf in South Africa.

Plant disease·2019
Same author

First Report of Sclerotium rolfsii on Kenaf in South Africa.

Plant disease·2019
Same author

Bronchodilating effects of salbutamol from a novel inhaler Airmax.

Respiratory medicine·2002
Same author

Christian (Chris) Neethling Barnard, 1922-2001.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2002
Same author

Injection sclerotherapy for variceal bleeding in patients with irresectable hepatocellular carcinoma.

Hepato-gastroenterology·2001

Area of Science:

  • Gastroenterology
  • Hepatology
  • Interventional Endoscopy

Background:

  • Esophageal variceal bleeding is a serious complication of portal hypertension.
  • Injection sclerotherapy is the current standard for managing acute and chronic variceal bleeding.
  • Management of refractory cases and long-term control presents ongoing challenges.

Purpose of the Study:

  • To review current and emerging treatment modalities for esophageal variceal bleeding.
  • To discuss the role of various interventions in acute and long-term management.
  • To highlight areas of controversy and future research directions.

Main Methods:

  • Review of existing literature on esophageal variceal bleeding treatments.
  • Analysis of the efficacy and limitations of sclerotherapy, surgical shunts, and transection.

Related Experiment Videos

  • Evaluation of pharmacological agents, variceal banding, transjugular intrahepatic porto-systemic shunts (TIPS), and liver transplantation.

    • Main Results:

    • Sclerotherapy is effective for acute bleeding and long-term management, but alternatives are needed for failures.
    • Surgical shunts or transection are options for refractory acute bleeding and long-term management failures.
    • The roles of pharmacological agents, variceal banding, and TIPS require further definition.
    • Liver transplantation is a consideration for end-stage liver disease patients, influencing emergency treatment planning.
    • Prophylactic therapy is not yet justified for unbled varices due to risk stratification challenges.
    • Portal hypertensive gastropathy is an underdiagnosed entity, typically manageable with propranolol or shunts.

    Conclusions:

    • Injection sclerotherapy remains the cornerstone for esophageal variceal bleeding management.
    • A range of surgical and endoscopic interventions exist for refractory cases, with evolving roles for newer techniques like variceal banding and TIPS.
    • Liver transplantation is a definitive option for select patients with end-stage liver disease.
    • Further research is needed to clarify the optimal use of pharmacological agents and identify high-risk patients for prophylactic therapy.